Literature DB >> 1636701

Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity.

L C Groop1, R C Bonadonna, D C Simonson, A S Petrides, M Shank, R A DeFronzo.   

Abstract

The dose-response relationship between the plasma insulin concentration and oxidative and nonoxidative pathways of free fatty acid (FFA) metabolism was examined in 11 obese and 7 lean subjects using a stepwise insulin clamp technique in combination with indirect calorimetry and infusion of [1-14C]palmitate. The fasting plasma FFA concentration was elevated in obese subjects (793 +/- 43 vs. 642 +/- 39 mumol/l; P less than 0.01) and was associated with an increased basal rate of plasma FFA turnover, FFA oxidation, and nonoxidative FFA disposal, i.e., reesterification (all P less than 0.01). Suppression of plasma FFA turnover by physiological increments in plasma insulin was impaired in obese compared with lean subjects. However, plasma FFA turnover expressed per kilogram fat mass was normally suppressed by insulin in obese subjects. Although insulin suppressed plasma FFA oxidation to the same extent in lean and obese subjects, inhibition of total lipid oxidation by insulin was impaired in the obese group. Obese subjects had an enhanced basal rate of nonoxidative FFA disposal, which was suppressed less by physiological increments in plasma insulin compared with lean controls. Therefore, we conclude that 1) lipolysis in uncomplicated obesity is normally sensitive to insulin; the enhanced FFA flux is simply a consequence of the increased fat mass. 2) Nonoxidative FFA disposal expressed per lean body mass is enhanced in obese subjects and correlates with the increase in plasma FFA concentration and fat mass. 3) Enhanced oxidation of intracellular lipids contributes to the enhanced rate of total lipid oxidation in obese subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1636701     DOI: 10.1152/ajpendo.1992.263.1.E79

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

1.  Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T.

Authors:  Xiaojuan Li; Jack F Youngren; Ben Hyun; Giorgos K Sakkas; Kathleen Mulligan; Sharmila Majumdar; Umesh B Masharani; Morris Schambelan; Ira D Goldfine
Journal:  Magn Reson Imaging       Date:  2007-08-02       Impact factor: 2.546

Review 2.  Skeletal muscle membrane lipids and insulin resistance.

Authors:  L H Storlien; D A Pan; A D Kriketos; J O'Connor; I D Caterson; G J Cooney; A B Jenkins; L A Baur
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

3.  Gender differences in insulin-induced free fatty acid suppression: studies in an African American population.

Authors:  A E Sumner; H Kushner; C A Lakota; B Falkner; J B Marsh
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

4.  Hydroxyeicosapentaenoic acids from the Pacific krill show high ligand activities for PPARs.

Authors:  Hidetoshi Yamada; Eriko Oshiro; Sayaka Kikuchi; Mayuka Hakozaki; Hideyuki Takahashi; Ken-Ichi Kimura
Journal:  J Lipid Res       Date:  2014-03-25       Impact factor: 5.922

5.  Gender differences in regional fatty acid metabolism before and after meal ingestion.

Authors:  M D Jensen
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

Authors:  H O Steinberg; H Chaker; R Leaming; A Johnson; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

Review 7.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

8.  β-Cell lipotoxicity after an overnight intravenous lipid challenge and free fatty acid elevation in African American versus American white overweight/obese adolescents.

Authors:  Kara S Hughan; Riccardo C Bonadonna; SoJung Lee; Sara F Michaliszyn; Silva A Arslanian
Journal:  J Clin Endocrinol Metab       Date:  2013-03-22       Impact factor: 5.958

Review 9.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26

Review 10.  Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.

Authors:  Ralph A DeFronzo; Devjit Tripathy
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.